Hong Kong, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Click Holdings Limited (“Click Holdings” or “Click” or “we” or “us”, NASDAQ: CLIK) and its subsidiaries (collectively, the “Company”), Hong Kong's only Nasdaq-listed leader in human resources and senior care solutions, announced to acquire 100% equity interest in Bowser Human Resources Limited (“Bowser”) and Top Team Consultants Limited (“Top Team”), being two Hong Kong-based human resources solutions providers operating in the region, by the issuance of 1,885,350 and 232,256 Class A ordinary shares of the Company respectively. These acquisitions will supercharge Click's strategic growth, unlock synergies, and propel the Company to new …

The healthcare sector's renewed momentum offers fertile ground for investors wanting to outperform by picking the best stocks from the broader indexes. Goldman Sachs identified 29 healthcare stocks in the Russell 1000 universe with positive recent consensus revisions to 2026 EPS estimates and that trade at attractive valuations. Goldman sees "more opportunity for alpha than beta" as wide return dispersion and increasing M&A activity in healthcare may favor selected winners.

Preliminary Expected Fourth Quarter 2025 Revenue of $137.5 to $138.5 Million Preliminary Expected Full Year 2025 Revenue of $512.5 to $513.5 Million

Largest real-world analysis of AI-driven breast cancer screening in US demonstrates increased cancer detection rate, consistency across patient populations

NEEDHAM, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced it will host a virtual Research and Development (R&D) Event from 11:00 am – 1:45 pm ET on Friday, December 5, 2025.

MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of its New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for gedatolisib in hormone receptor positive (“HR+”), human epidermal growth factor receptor 2 negative (“HER2-”), advanced breast cancer (“ABC”). The NDA was submitted under the FDA's Real-Time Oncology Review (“RTOR”) program, which is intended to facilitate shorter regulatory review periods. Gedatolisib previously received both Breakthrough Therapy and Fast Track designations based on promising preliminary clinical data. The …

MALVERN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of (i) restricted stock units covering 30,200 shares of its common stock to seventeen newly-hired employees and (ii) an option to purchase 25,000 shares of its common stock to one employee, with a grant date of November 10, 2025 (the "Grant Date"). The equity awards were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception …

MAUMEE, Ohio , Nov. 17, 2025 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE) announces that it will present at the Stephens Annual Investment Conference on Wednesday, November 19, 2025. President and Chief Executive Officer Bill Krueger and Executive Vice President and Chief Financial Officer Brian Valentine will speak at the conference at 3 p.m.

RENTON, Wash. , Nov. 17, 2025 /PRNewswire/ -- Radiant Logistics, Inc. (NYSE American: RLGT), a technology-enabled global transportation and value-added logistics services company, today announced that its board of directors has authorized the repurchase of up to five million shares of the Company's common stock through December 31, 2027.

Transaction Highlights Raised $975.0 million gross proceeds through a new offering of convertible senior notes due in November 2031 Has agreed to repurchase approximately $755.7 million principal amount of existing 1.25% convertible notes due in 2026 NEWARK, Calif. , Nov. 17, 2025 /PRNewswire/ -- Lucid Group, Inc. (Nasdaq: LCID), maker of the world's most advanced electric vehicles, today announced the closing of $975.0 million aggregate principal amount of convertible senior notes due 2031, including the exercise in full of the option granted to the initial purchasers to purchase up to $100.0 million aggregate principal amount of notes.

TORRANCE, Calif. , Nov. 17, 2025 (GLOBE NEWSWIRE) -- Navitas Semiconductor, an industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, has announced participation in the following upcoming investor event:

Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million. Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30% to $2.9 million.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands”, “Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced the release of its updated investor presentation, outlining the Company's strategic growth roadmap, category diversification, and financial performance milestones across its global platform.

CLEARWATER Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that it is commencing an underwritten public offering of shares of its common stock (or common stock equivalents). The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

WARSAW, N.Y., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Financial Institutions, Inc. (Nasdaq: FISI) (the “Company”), parent company of Five Star Bank and Courier Capital, LLC, announced that on November 14, 2025, its Board of Directors approved a quarterly cash dividend of $0.31 per outstanding common share.

OAKLAND, Calif.--(BUSINESS WIRE)--ThredUp (NASDAQ: TDUP, LTSE: TDUP), one of the largest online resale platforms for apparel, shoes, and accessories, today announced the appointment of Kelly Bodnar Battles to its Board of Directors, with the appointment becoming effective on December 1, 2025. Upon the effective date, Battles will assume the role of Audit Committee Chair. This appointment reinforces ThredUp's continued commitment to strengthening its financial governance as the company accelerat.

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced the Company will participate in the 7th Annual Wolfe Research Healthcare Conference, which is being held November 17-19, 2025, at the Wolfe Research offices in New York, NY. Richard D. Phillips, Chief Executive Officer, and Jana T. Croom, Chief Financial Officer, are scheduled to present on Tuesday, November 18, 2025, at 10:40 a.m. Eastern Time. A webcast of the presentation will be available on the Events &am.

NELSONVILLE, Ohio--(BUSINESS WIRE)--Rocky Brands, Inc. (NASDAQ: RCKY) today announced that its board of directors has declared a quarterly cash dividend of $0.155 per share of outstanding common stock, which will be paid on December 15, 2025, to all shareholders of record as of the close of business on December 1, 2025. The declaration and payment of future dividends and the establishment of future record dates and payment dates are subject to the quarterly determination of the board of directo.

SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence announced the appointment of Dr. Luc Van den hove to its board of directors, effective January 1, 2026.

ARLINGTON, Va.--(BUSINESS WIRE)--CoStar Group, Inc. (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information, analytics, and 3D digital twin technology in the property markets, will present at Stephens 27th Annual Investment Conference. CFO Chris Lown and Head of Investor Relations Rich Simonelli will participate in a fireside chat on Thursday, November 20, 2025, at 9:00 a.m. CT. Live and recorded versions of the webcast will both be available under the Events & Pr.